Baxter Net Income 2006-2018 | BAX

Baxter annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Baxter net income for the quarter ending December 31, 2018 was $0.348B, a 590.14% decline year-over-year.
  • Baxter net income for the twelve months ending December 31, 2018 was $1.624B, a 126.5% increase year-over-year.
  • Baxter annual net income for 2018 was $1.624B, a 126.5% increase from 2017.
  • Baxter annual net income for 2017 was $0.717B, a 85.56% decline from 2016.
  • Baxter annual net income for 2016 was $4.965B, a 412.91% increase from 2015.
Baxter Annual Net Income
(Millions of US $)
2018 $1,624
2017 $717
2016 $4,965
2015 $968
2014 $2,497
2013 $2,012
2012 $2,326
2011 $2,224
2010 $1,420
2009 $2,205
2008 $2,014
2007 $1,707
2006 $1,397
2005 $956
Baxter Quarterly Net Income
(Millions of US $)
Q4 2018 $348
Q3 2018 $544
Q2 2018 $343
Q1 2018 $389
Q4 2017 $-71
Q3 2017 $251
Q2 2017 $265
Q1 2017 $272
Q4 2016 $243
Q3 2016 $130
Q2 2016 $1,212
Q1 2016 $3,380
Q4 2015 $205
Q3 2015 $1
Q2 2015 $332
Q1 2015 $430
Q4 2014 $953
Q3 2014 $468
Q2 2014 $520
Q1 2014 $556
Q4 2013 $326
Q3 2013 $544
Q2 2013 $590
Q1 2013 $552
Q4 2012 $494
Q3 2012 $583
Q2 2012 $661
Q1 2012 $588
Q4 2011 $463
Q3 2011 $576
Q2 2011 $615
Q1 2011 $570
Q4 2010 $423
Q3 2010 $525
Q2 2010 $535
Q1 2010 $-63
Q4 2009 $572
Q3 2009 $530
Q2 2009 $587
Q1 2009 $516
Q4 2008 $569
Q3 2008 $472
Q2 2008 $544
Q1 2008 $429
Q4 2007 $478
Q3 2007 $395
Q2 2007 $431
Q1 2007 $403
Q4 2006 $432
Q3 2006 $374
Q2 2006 $309
Q1 2006 $282
Q4 2005 $292
Q3 2005 $116
Q2 2005 $322
Q1 2005 $226
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $39.019B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.667B 26.06
Medtronic (MDT) Ireland $114.132B 16.69
Stryker (SYK) United States $69.756B 24.90
Boston Scientific (BSX) United States $49.905B 24.25
Zimmer Biomet Holdings (ZBH) United States $25.114B 16.07
Smith & Nephew SNATS (SNN) United Kingdom $16.786B 0.00
Canopy Growth (CGC) Canada $16.315B 0.00
ResMed (RMD) United States $14.544B 27.58
Aurora Cannabis (ACB) Canada $9.179B 64.71
Bio-Rad Laboratories (BIO) United States $8.795B 50.45
Perrigo (PRGO) Ireland $6.734B 10.92
Hill-Rom Holdings (HRC) United States $6.397B 19.79
GW Pharmaceuticals (GWPH) United Kingdom $4.994B 0.00
Insulet (PODD) United States $4.964B 1664.20
ICU Medical (ICUI) United States $4.636B 28.71
Haemonetics (HAE) United States $4.354B 38.62
Hutchison China MediTech (HCM) China $3.962B 0.00
Agios Pharmaceuticals (AGIO) United States $3.443B 0.00
Neogen (NEOG) United States $3.004B 48.85
NuVasive (NUVA) United States $2.967B 25.77
Quidel (QDEL) United States $2.487B 22.25
National Vision Holdings (EYE) United States $2.276B 44.77
Aphria (APHA) $1.957B 0.00
HEXO (HEXO) $1.474B 0.00
Phibro Animal Health (PAHC) United States $1.338B 19.24
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.212B 870.25
AtriCure (ATRC) United States $1.076B 0.00
Lantheus Holdings (LNTH) United States $0.957B 25.86
Omeros (OMER) United States $0.929B 0.00
PetIQ (PETQ) United States $0.865B 24.76
Cerus (CERS) United States $0.831B 0.00
MacroGenics (MGNX) United States $0.820B 0.00
NanoString Technologies (NSTG) United States $0.781B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.725B 24.66
TG Therapeutics (TGTX) United States $0.717B 0.00
Evolus (EOLS) United States $0.708B 0.00
OraSure Technologies (OSUR) United States $0.589B 25.68
Surmodics (SRDX) United States $0.584B 84.94
LeMaitre Vascular (LMAT) United States $0.555B 26.37
Meridian Bioscience (VIVO) United States $0.538B 16.02
Quanterix (QTRX) United States $0.515B 0.00
Insys Therapeutics (INSY) United States $0.332B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.19
BioLife Solutions (BLFS) United States $0.302B 124.61
Vapotherm (VAPO) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.270B 0.00
Cytosorbents (CTSO) United States $0.228B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.172B 18.38
Bovie Medical (APYX) United States $0.140B 0.00
Chimerix (CMRX) United States $0.138B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Surface Oncology (SURF) United States $0.114B 0.00
United-Guardian (UG) United States $0.089B 20.32
Female Health (VERU) United States $0.088B 0.00
InfuSystems Holdings (INFU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
GUARDION HEALTH (GHSI) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.024B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00